
Nephrologist

No OPD information available
Fanconi Bickel Syndrome
Fanconi Syndrome
Aminoaciduria
ABO Incompatibility
Chronic Kidney Disease
Febrile Neutropenia
Focal Segmental Glomerulosclerosis
Hemolytic Transfusion Reaction
Hepatitis
HIV/AIDS
Hypophosphatemia
Interstitial Nephritis
Kaposi Sarcoma
Kidney Transplant
Liver Transplant
Low Potassium Level
Low Sodium Level
Primary Hyperoxaluria
Primary Hyperoxaluria Type 1
Rhabditida Infections
Rhabdomyolysis
Strongyloidiasis
David M. Gracey is a male medical professional who helps people with various health conditions like Fanconi Bickel Syndrome, chronic kidney disease, and HIV/AIDS. He also treats issues such as low potassium level, hepatitis, and kidney transplants. David has special skills in handling cases like ABO incompatibility and rhabdomyolysis.
David communicates with patients in a friendly and clear way, making them feel comfortable and understood. Patients trust him because he listens carefully to their concerns and explains things in a simple manner. He stays updated with the latest medical knowledge by attending conferences, reading research papers, and collaborating with other experts in the field.
David works well with his colleagues, sharing knowledge and expertise to provide the best care for patients. His approach to teamwork is collaborative and respectful, ensuring that everyone's input is valued. He has published research on wound complications in kidney transplantation and has conducted clinical trials to improve treatments for anemia associated with chronic kidney disease.
Through his work, David has positively impacted many patients' lives by providing effective treatments and compassionate care. His dedication to staying informed and his commitment to ongoing research contribute to better outcomes for those under his care. Patients appreciate his expertise, empathy, and dedication to improving their health.
In summary, David M. Gracey is a skilled and caring medical professional who goes above and beyond to help his patients and contribute to advancements in the field of medicine.
Enrollment Status: Completed
Published: April 02, 2024
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
